Singulair junior 5 mg tablete za žvakanje
| Name | Singulair junior 5 mg tablete za žvakanje |
|---|---|
| Marketing Authorisation Number | HR-H-436317310 |
| Active Substance | montelukastnatrij |
| Composition | jedna tableta za žvakanje sadrži 5 mg montelukasta (u obliku montelukastnatrija) |
| Pharmaceutical Form | tableta za žvakanje |
| Manufacturer | Merck Sharp & Dohme B.V., Haarlem, Nizozemska Organon Heist bv, Heist-op-den-Berg, Belgija |
| Marketing Authorisation Holder | Organon Pharma d.o.o., Slavonska Avenija 1c, Zagreb, Hrvatska |
| Marketing Authorisation Date | 09.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/231 |
| Registration Number | 381-12-01/154-21-61 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03DC03 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
